Skip to main content
Veterinary Medicines

Defendog 20 mg/ml Oplossing voor cutaan gebruik

Not authorised
  • Permethrin (40:60)

Product identification

Medicine name:
Defendog 20 mg/ml Oplossing voor cutaan gebruik
Defendog 20 mg/ml Solution pour application cutanée
Defendog 20 mg/ml Lösung zur Anwendung auf der Haut
Active substance:
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Permethrin (40:60)
    2.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC04
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Defendog 20 mg/ml Cutaneous solution Bottle of 500 ml
  • Defendog 20 mg/ml Cutaneous solution Bottle of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V175016
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/02/2022
French (PDF)
Published on: 10/02/2022
German (PDF)
Published on: 10/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/02/2022
French (PDF)
Published on: 10/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."